RankAlpha logo
Back to Rankings

GTBP

GT BiopharmaD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
GTBP vs peer average
44/100
GTBP vs. peer average (D vs. D)
Grade spread
A 2 · D 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

BLRX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $15.83M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBLRXBioLineRX
GTBP
GT Biopharma
BLRX
BioLineRX
Grade
D
F
Momentum
48
13
Value
41
42
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs BLRX

GTBP / BLRX
Grade Position
Below peers
GTBP vs. peer average (D vs. D)
44/100
Momentum
48
GTBP
Value
41
BLRX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GTBP
1
BLRX
BioLineRX Ltd ADR
F
20/100
+1
2
HIND
Vyome Holdings Inc Common
F
20/100
+1
3
AKTX
Akari Therapeutics Plc ADR
D
40/100
Even
4
COCP
Cocrystal Pharma Inc Common
A
100/100
-3
5
LEXX
Lexaria Bioscience Corp Common
D
40/100
Even
BLRX is the first peer returned for this comparison set.